Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C
This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis.
Cost Variation and Savings Opportunities in the Oncology Care Model
Geographic variation in cancer treatment spending reveals that chemotherapy and hospital inpatient care may offer opportunities for savings for practices participating in the Oncology Care Model.
Modeling the Impacts of Restrictive Formularies on Patients With HIV
Constraining access to HIV regimens can have significant implications for patients. This study examined the economic and health impacts of restrictive HIV formulary designs.
